Clinic
Southern Mono Health Care District
Southern Mono Health Care District was paid $2.72M by Medicaid between Jan 2018 and Nov 2024, across 84 billing codes. Its largest line is 97140, Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) — 21% of everything it billed.
33Billing provider infoSOUTHERN MONO HEALTH CARE DISTRICT
MAMMOTH LAKES, CA 93546
MAMMOTH LAKES, CA 93546
33aNPI1962444059assigned 06/12/2006
33bProvider typeCritical Access Hospital Clinic/Center
28Total paid$2.72M
24GClaims82,316
24DCodes billed84
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,431 | $486K | |
| 2019 | 9,915 | $391K | |
| 2020 | 8,060 | $273K | |
| 2021 | 10,764 | $304K | |
| 2022 | 14,129 | $445K | |
| 2023 | 14,862 | $502K | |
| 2024incomplete | 11,155 | $321K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 21% | 11,754 | 3,768 | $573K |
| 0450 | Emergency room services | 14% | 5,493 | 4,808 | $384K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 11% | 12,251 | 4,253 | $289K |
| 0250 | 8.8% | 1,114 | 699 | $239K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.4% | 3,110 | 2,956 | $203K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.6% | 3,481 | 3,253 | $152K |
| 99199 | Unlisted special service, procedure or report | 4.1% | 2,224 | 1,949 | $113K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.9% | 936 | 907 | $78K |
| 80053 | Comprehensive metabolic panel | 2.8% | 5,632 | 5,124 | $76K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.8% | 2,292 | 2,266 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 5,065 | 4,610 | $49K |
| 97750 | 1.4% | 1,077 | 959 | $38K |
72 more codes
| 80061 | Lipid panel | 1.2% | 2,305 | $34K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.2% | 1,213 | $33K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.1% | 870 | $30K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.0% | 1,331 | $27K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 594 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,232 | $25K |
| 0270 | <1% | 117 | $25K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 495 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,885 | $22K |
| 0259 | <1% | 502 | $21K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 973 | $21K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 315 | $16K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 460 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 536 | $13K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 160 | $12K |
| 87631 | <1% | 179 | $11K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 273 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 307 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 167 | $9K |
| 84484 | <1% | 88 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 147 | $6K |
| 86703 | <1% | 364 | $6K | |
| 86780 | <1% | 178 | $6K | |
| 99285 | Emergency room visit (most serious) | <1% | 52 | $5K |
| 86803 | <1% | 259 | $5K | |
| 97161 | <1% | 340 | $5K | |
| 81003 | <1% | 1,533 | $4K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 356 | $4K |
| 83690 | <1% | 432 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 98 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,871 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 59 | $3K |
| Z7502 | <1% | 89 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 122 | $3K |
| 0257 | <1% | 1,343 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 289 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 52 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 83 | $2K |
| 81001 | <1% | 305 | $2K | |
| 81025 | <1% | 307 | $2K | |
| 86140 | <1% | 216 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 131 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 18 | $1K |
| 84439 | <1% | 102 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 26 | $1K |
| 84153 | <1% | 40 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $965.29 |
| 85027 | <1% | 114 | $879.98 | |
| 97803 | <1% | 14 | $754.14 | |
| 87340 | <1% | 42 | $708.18 | |
| 85018 | <1% | 239 | $646.41 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 80 | $557.84 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $462.67 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $302.49 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $265.86 |
| 85651 | <1% | 65 | $238.88 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15 | $225.00 |
| 85610 | <1% | 30 | $212.99 | |
| J3490 | Unclassified drugs | <1% | 18 | $184.87 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 56 | $149.72 |
| 99173 | <1% | 39 | $126.56 | |
| 87276 | <1% | 12 | $110.11 | |
| 83735 | <1% | 14 | $108.00 | |
| J7070 | Infusion, d5w, 1000 cc | <1% | 12 | $80.16 |
| 87186 | <1% | 18 | $78.82 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $78.18 |
| 87077 | <1% | 19 | $69.25 | |
| 87275 | <1% | 12 | $64.91 | |
| 85007 | <1% | 28 | $64.77 | |
| 90686 | <1% | 15 | $36.00 | |
| 0637 | <1% | 48 | $2.24 | |
| 99001 | 0% | 118 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVAN WINKLE, MELANIE (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Southern Mono Health Care District | Mammoth Lakes, CA | $24.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.